For best results when printing this announcement, please click on link below:
http://pdf.reuters.com/htmlnews/htmlnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20170721:nGNE5ypLBB
21 July 2017
Mothercare plc
Director/PDMR shareholdings
Mothercare plc has received notification of the following transaction in its
ordinary shares. In accordance with Article 19 of the EU Market Abuse
Regulation, the relevant FCA notification is set out below.
Following the transaction, the total beneficial interest in the Company held
by Mr Newton-Jones is 363,972 ordinary shares, 0.213% of the total voting
rights.
Mothercare plc (the "Company")
Transaction notification
1.
Details of PDMR / person closely associated with them ("PCA") / other
Restricted Persons
a)
Name
Mark Newton-Jones
b)
Position / status
CEO
c)
Initial notification / amendment
Initial notification
2.
Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a)
Description of the financial instrument
Ordinary shares of 50p each
b)
Nature of the transaction
Acquisition
c)
Price(s) and volume(s)
Price(s) Volume(s)
105.22p per share 95,000
d)
Aggregated information
* Aggregated volume
* Price
N/A
e)
Date of the transaction
2017-07-21
(yyyy-mm-date)
f)
Place of the transaction
London Stock Exchange
Further information: investorrelations@mothercare.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of
Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for
the content, accuracy and originality of the information contained therein.
Source: Mothercare Plc via Globenewswire